The United Nations Development Assistance Framework (UNDAF) 2018-2022 sets out the UN partnership aiming to support Nepal as it carves out its development agenda over the next five years. At the core of this new UNDAF are the SDGs, the Government of Nepal’s Fourteenth Plan, and international commi...tments and norms to which Nepal is a party. Leaping off from the lessons learned from the previous UNDAF (2013-2017), this new framework builds upon successes, incorporates emerging issues and agreements, and serves to address Nepal’s larger economic, social, and environmental objectives.
more
WHO working group on HIV incidence assays meeting report
10–11 December 2015
Glion, Switzerland
UNAIDS/WHO working group on global HIV/AIDS and STI surveillance
WHO/HIV/2017.03
Research results of sexual and gender-based violence (SGBV) prevention and response before, during and after disasters in Indonesia, Lao PDR and the Philippines
This report contributes new evidence on why and how sexual and gender-based violence (SGBV) risks increase during humanitarian disasters.... It details how humanitarian actors can better prevent and respond to such escalation of SGBV, and better meet the needs of affected women, girls, men and boys. This research is based on community views of disaster-affected women, adolescent girls, men and adolescent boys in three South-East Asian countries: Indonesia, Lao PDR and the Philippines.
more
Toolkit regarding Zika Virus
A tool for measuring alcohol policy implementation
A handbook for leaders and managers
Over the past 50 years, dengue has spread from nine to over a hundred countries, making it the most rapidly spreading vector-borne disease. Yet, dengue continues to have a low profile among policy-makers and donors and does not receive the media attention it deserves. While there is no vaccine or cu...re for dengue, it can be managed and prevented. We need a renewed commitment to integrated programming that includes improved management and diagnosis, increased awareness and community participation in controlling the vector and enhanced environmental sanitation
more
Building laboratory testing capacity
Preferred product characteristics and clinical development considerations